GSK decides it's time to start the PR machine and develpments wheel.
Like Outboard Jack wrote, "pick up the pieces".
Old management leaves: implosion, dust and flying stuff.
Dust settles, things settle and calm down.
Eventually, things start to move a little again, pick up the pieces and begin to rebuid "something" once again.
Meanwhile, remember, nothing has changed (at all) with Heplisav. Still the same as it was in February; same as it was back last November and in May of 2012 before.
When the FDA does "render something" it will be amusing to hear or read their rendering:
"Well, despite the fact that your company hasn't done anything or changed anything with the vaccine candidate, the "recent changes" which you have made have led our agency to like the vaccine candidate much, MUCH more." We would like to move to an expedited approval track so that everyone and their kid sister could be made available to receive the vaccine as soon as possible."
In real estate its, "location, location, location!"
I guess the same is true with biotech / pharma; you move the drug candidate from "this location" to "that location" and suddenly it changes how the candidate gets treated.
Can't wait to see that one.
Oh well, we will just have wait out the "nothing" until GSK signals that things are ready to "go".